PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
Eugia Pharma Specialities restarts production at terminally sterilized product lines
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Patients visiting OPD sections of hospitals use their Ayushman Bharat Health Account (ABHA) to get instant tokens to save time spent in registration queues
Subscribe To Our Newsletter & Stay Updated